CCL21 and atherosclerosis: Variations in pro-inflammatory biomarkers such as soluble vascular cell adhesion molecule-1 (sVCAM-1) and Chemokine (C-C motif) ligand 21 (CCL-21) in MINOCA patients suggest that plaque structure changes and microcirculatory alterations contribute to atherosclerosis progression.